NERV Annual CFO
-$14.78 M
+$9.86 M+40.01%
31 December 2023
Summary:
As of January 22, 2025, NERV annual cash flow from operations is -$14.78 million, with the most recent change of +$9.86 million (+40.01%) on December 31, 2023. During the last 3 years, it has risen by +$19.04 million (+56.29%). NERV annual CFO is now -578.02% below its all-time high of $3.09 million, reached on December 31, 2017.NERV Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NERV Quarterly CFO
-$4.35 M
-$414.90 K-10.54%
30 September 2024
Summary:
As of January 22, 2025, NERV quarterly cash flow from operations is -$4.35 million, with the most recent change of -$414.90 thousand (-10.54%) on September 30, 2024. Over the past year, it has increased by +$453.90 thousand (+9.44%). NERV quarterly CFO is now -117.48% below its all-time high of $24.89 million, reached on September 30, 2017.NERV Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NERV TTM CFO
-$20.38 M
+$453.90 K+2.18%
30 September 2024
Summary:
As of January 22, 2025, NERV TTM cash flow from operations is -$20.38 million, with the most recent change of +$453.90 thousand (+2.18%) on September 30, 2024. Over the past year, it has dropped by -$7.47 million (-57.90%). NERV TTM CFO is now -758.77% below its all-time high of $3.09 million, reached on December 31, 2017.NERV TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NERV Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +40.0% | +9.4% | -57.9% |
| 3 y3 years | +56.3% | +9.4% | -57.9% |
| 5 y5 years | +64.8% | +9.4% | -57.9% |
NERV Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.0% | -3671.4% | +54.4% | -57.9% | +19.7% |
| 5 y | 5-year | at high | +66.0% | -3671.4% | +69.3% | -57.9% | +53.1% |
| alltime | all time | -578.0% | +66.0% | -117.5% | +84.0% | -758.8% | +53.8% |
Minerva Neurosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.35 M(+10.5%) | -$20.38 M(-2.2%) |
| June 2024 | - | -$3.94 M(-35.4%) | -$20.83 M(+0.3%) |
| Mar 2024 | - | -$6.09 M(+1.7%) | -$20.76 M(+40.4%) |
| Dec 2023 | -$14.78 M(-40.0%) | -$5.99 M(+24.7%) | -$14.78 M(+14.6%) |
| Sept 2023 | - | -$4.81 M(+24.1%) | -$12.90 M(-26.8%) |
| June 2023 | - | -$3.87 M(+3255.2%) | -$17.63 M(-7.0%) |
| Mar 2023 | - | -$115.40 K(-97.2%) | -$18.95 M(-23.1%) |
| Dec 2022 | -$24.65 M(+0.2%) | -$4.11 M(-56.9%) | -$24.65 M(-2.8%) |
| Sept 2022 | - | -$9.53 M(+83.6%) | -$25.37 M(+3.7%) |
| June 2022 | - | -$5.19 M(-10.6%) | -$24.46 M(-2.9%) |
| Mar 2022 | - | -$5.81 M(+20.2%) | -$25.19 M(+2.4%) |
| Dec 2021 | -$24.60 M(-27.3%) | -$4.83 M(-44.0%) | -$24.60 M(-8.6%) |
| Sept 2021 | - | -$8.63 M(+45.6%) | -$26.93 M(-4.4%) |
| June 2021 | - | -$5.92 M(+13.6%) | -$28.17 M(-5.6%) |
| Mar 2021 | - | -$5.22 M(-27.1%) | -$29.84 M(-11.8%) |
| Dec 2020 | -$33.82 M(-22.1%) | -$7.16 M(-27.5%) | -$33.82 M(-17.2%) |
| Sept 2020 | - | -$9.87 M(+30.1%) | -$40.84 M(+0.9%) |
| June 2020 | - | -$7.59 M(-17.5%) | -$40.49 M(-5.9%) |
| Mar 2020 | - | -$9.20 M(-35.1%) | -$43.03 M(-0.9%) |
| Dec 2019 | -$43.43 M(+3.6%) | -$14.18 M(+48.9%) | -$43.43 M(+11.2%) |
| Sept 2019 | - | -$9.52 M(-6.0%) | -$39.05 M(-1.2%) |
| June 2019 | - | -$10.13 M(+5.5%) | -$39.51 M(-2.7%) |
| Mar 2019 | - | -$9.60 M(-2.0%) | -$40.61 M(-3.2%) |
| Dec 2018 | -$41.94 M | -$9.80 M(-1.9%) | -$41.94 M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$9.98 M(-11.1%) | -$41.05 M(+564.8%) |
| June 2018 | - | -$11.23 M(+2.7%) | -$6.18 M(+244.2%) |
| Mar 2018 | - | -$10.93 M(+22.7%) | -$1.79 M(-158.0%) |
| Dec 2017 | $3.09 M(-112.0%) | -$8.91 M(-135.8%) | $3.09 M(+0.5%) |
| Sept 2017 | - | $24.89 M(-463.7%) | $3.08 M(-111.6%) |
| June 2017 | - | -$6.84 M(+13.2%) | -$26.47 M(+3.1%) |
| Mar 2017 | - | -$6.04 M(-32.3%) | -$25.68 M(-0.0%) |
| Dec 2016 | -$25.69 M(+5.8%) | -$8.93 M(+91.7%) | -$25.69 M(+10.0%) |
| Sept 2016 | - | -$4.66 M(-23.1%) | -$23.36 M(-4.4%) |
| June 2016 | - | -$6.05 M(+0.1%) | -$24.43 M(-3.8%) |
| Mar 2016 | - | -$6.05 M(-8.4%) | -$25.41 M(+4.7%) |
| Dec 2015 | -$24.27 M(-32.5%) | -$6.60 M(+15.3%) | -$24.27 M(+7.0%) |
| Sept 2015 | - | -$5.73 M(-18.5%) | -$22.68 M(-48.6%) |
| June 2015 | - | -$7.03 M(+43.2%) | -$44.12 M(+11.3%) |
| Mar 2015 | - | -$4.91 M(-2.1%) | -$39.63 M(+10.2%) |
| Dec 2014 | -$35.96 M(+1564.7%) | -$5.02 M(-81.5%) | -$35.96 M(+11.8%) |
| Sept 2014 | - | -$27.16 M(+967.6%) | -$32.15 M(+498.2%) |
| June 2014 | - | -$2.54 M(+105.2%) | -$5.38 M(+66.9%) |
| Mar 2014 | - | -$1.24 M(+2.4%) | -$3.22 M(+49.1%) |
| Dec 2013 | -$2.16 M(+137.8%) | -$1.21 M(+217.1%) | -$2.16 M(+127.4%) |
| Sept 2013 | - | -$381.70 K(-2.0%) | -$950.00 K(+67.2%) |
| June 2013 | - | -$389.40 K(+117.7%) | -$568.30 K(+217.7%) |
| Mar 2013 | - | -$178.90 K | -$178.90 K |
| Dec 2012 | -$908.50 K | - | - |
FAQ
- What is Minerva Neurosciences annual cash flow from operations?
- What is the all time high annual CFO for Minerva Neurosciences?
- What is Minerva Neurosciences annual CFO year-on-year change?
- What is Minerva Neurosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Minerva Neurosciences?
- What is Minerva Neurosciences quarterly CFO year-on-year change?
- What is Minerva Neurosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Minerva Neurosciences?
- What is Minerva Neurosciences TTM CFO year-on-year change?
What is Minerva Neurosciences annual cash flow from operations?
The current annual CFO of NERV is -$14.78 M
What is the all time high annual CFO for Minerva Neurosciences?
Minerva Neurosciences all-time high annual cash flow from operations is $3.09 M
What is Minerva Neurosciences annual CFO year-on-year change?
Over the past year, NERV annual cash flow from operations has changed by +$9.86 M (+40.01%)
What is Minerva Neurosciences quarterly cash flow from operations?
The current quarterly CFO of NERV is -$4.35 M
What is the all time high quarterly CFO for Minerva Neurosciences?
Minerva Neurosciences all-time high quarterly cash flow from operations is $24.89 M
What is Minerva Neurosciences quarterly CFO year-on-year change?
Over the past year, NERV quarterly cash flow from operations has changed by +$453.90 K (+9.44%)
What is Minerva Neurosciences TTM cash flow from operations?
The current TTM CFO of NERV is -$20.38 M
What is the all time high TTM CFO for Minerva Neurosciences?
Minerva Neurosciences all-time high TTM cash flow from operations is $3.09 M
What is Minerva Neurosciences TTM CFO year-on-year change?
Over the past year, NERV TTM cash flow from operations has changed by -$7.47 M (-57.90%)